A detailed history of Jane Street Group, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 63,614 shares of AMPH stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,614
Previous 96,714 34.22%
Holding current value
$2.06 Million
Previous $3.87 Million 20.19%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.99 - $50.09 $1.22 Million - $1.66 Million
-33,100 Reduced 34.22%
63,614 $3.09 Million
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $2.24 Million - $2.52 Million
57,854 Added 148.88%
96,714 $3.87 Million
Q1 2024

May 15, 2024

SELL
$42.85 - $63.45 $562,149 - $832,400
-13,119 Reduced 25.24%
38,860 $1.71 Million
Q4 2023

Feb 14, 2024

BUY
$44.49 - $62.93 $528,007 - $746,853
11,868 Added 29.59%
51,979 $3.21 Million
Q3 2023

Nov 14, 2023

BUY
$45.51 - $65.0 $1.06 Million - $1.51 Million
23,297 Added 138.56%
40,111 $1.84 Million
Q2 2023

Aug 14, 2023

SELL
$35.77 - $58.38 $412,392 - $673,063
-11,529 Reduced 40.68%
16,814 $966,000
Q1 2023

May 15, 2023

BUY
$27.99 - $37.92 $562,431 - $761,964
20,094 Added 243.59%
28,343 $1.06 Million
Q4 2022

Feb 14, 2023

SELL
$27.93 - $31.27 $811,254 - $908,268
-29,046 Reduced 77.88%
8,249 $231,000
Q3 2022

Nov 14, 2022

BUY
$27.56 - $37.75 $543,207 - $744,052
19,710 Added 112.08%
37,295 $1.05 Million
Q3 2022

Nov 14, 2022

BUY
$27.56 - $37.75 $543,207 - $744,052
19,710 Added 112.08%
37,295 $1.05 Million
Q2 2022

Aug 16, 2022

BUY
$29.79 - $42.29 $247,525 - $351,387
8,309 Added 89.58%
17,585 $612,000
Q1 2022

May 17, 2022

SELL
$22.96 - $36.45 $231,666 - $367,780
-10,090 Reduced 52.1%
9,276 $333,000
Q4 2021

Feb 15, 2022

BUY
$18.14 - $23.29 $351,299 - $451,034
19,366 New
19,366 $451,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.59B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.